<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01281397</url>
  </required_header>
  <id_info>
    <org_study_id>Project code: 198-1980976-097</org_study_id>
    <nct_id>NCT01281397</nct_id>
  </id_info>
  <brief_title>Bleeding Prediction in Patients Following Cardiac Surgery Using Whole Blood Aggregometry and Thromboelastometry</brief_title>
  <official_title>Bleeding Prediction in Patients Undergoing Cardiac Surgery Using Whole Blood Impedance Aggregometry and Rotational Thromboelastometry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zagreb</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Hospital Centre Zagreb</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Science, Education and Sport, Republic of Croatia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zagreb</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of whole blood impedance aggregometry and rotational thromboelastometry can reveal useful
      data about platelet function and viscoelastic properties of blood clot in patients undergoing
      cardiac surgery.

      The purpose of this study is to clarify whether it is possible to predict patients on
      excessive risk of perioperative bleeding using whole blood impedance aggregometry and
      rotational thromoelastometry.

      Antiplatelet therapy is the cornerstone in treatment of patients with coronary artery
      disease. Another research goal is to determine the degree of response to antiplatelet therapy
      before and after surgery and to investigate whether patients by level of response to
      antiplatelet therapy before surgery have a higher risk of perioperative bleeding.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    After 148 patients enrolled, interim analysis revealed positive results in regard to primary
    hypothesis.
  </why_stopped>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chest tube output in first 24 hours</measure>
    <time_frame>24 hours after surgical procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Allogenic blood products transfusion</measure>
    <time_frame>7 days after surgery including the day of surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">148</enrollment>
  <condition>Heart Disease</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Aortic Valve Disease</condition>
  <condition>Mitral Valve Disease</condition>
  <arm_group>
    <arm_group_label>Patients undergoing elective cardiac surgery</arm_group_label>
    <description>Patients undergoing elective cardiac surgery will be enrolled in study. Data about antiplatelet therapy ingestion prior to surgery will be included.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing elective cardiac surgery with cardiopulmonary bypass are enrolled
        in study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. &gt; 18 years old

          2. Elective cardiac surgery patients

          3. Coronary artery disease

          4. Aortic valve disease

          5. Mitral valve disease

          6. Ascendent aorta aneurysm

          7. Combine coronary and valve disease

          8. Cardiac surgery procedures using cardiopulmonary bypass

        Exclusion Criteria:

          1. Missing consent

          2. Patients with emergent cardiac surgical procedures

          3. Patients on antiplatelet therapy other than aspirin or clopidogrel

          4. Patients with inaccurate antiplatelet therapy administration documentation

          5. Missing data

          6. Off-pump procedures

          7. Patients younger than 18 years old

          8. Patients with severe mental disorders

          9. Intrinsic coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mate Petricevic, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University hospital center Zagreb- Rebro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bojan Biocina, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>University hospital center Zagreb - Rebro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University hospital center Zagreb- Rebro</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2011</study_first_submitted>
  <study_first_submitted_qc>January 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2011</study_first_posted>
  <last_update_submitted>December 1, 2014</last_update_submitted>
  <last_update_submitted_qc>December 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zagreb</investigator_affiliation>
    <investigator_full_name>Petricevic Mate</investigator_full_name>
    <investigator_title>Mate Petricevic M.D. , Ph.D.</investigator_title>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>aggregometry</keyword>
  <keyword>thromboelastometry</keyword>
  <keyword>platelet function</keyword>
  <keyword>bleeding</keyword>
  <keyword>antiplatelet therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

